论文部分内容阅读
目的：观察痰热清注射液联合阿昔洛韦注射液联合治疗小儿水痘的临床疗效。方法将80例水痘患儿随机分为两组：治疗组和对照组，每组各40例，治疗组给予痰热清注射液（0.3~0.5ml/kg），1次/d，同时给与阿昔洛韦注射液（0.01g/kg），1次/d，静脉滴注，连续5~7d，对照组仅给予阿昔洛韦注射液（0.01g/kg），1次/d，连续5~7d，治疗后观察两组疗效，包括患儿发热持续时间、皮疹结痂、消退时间及不良反应。结果治疗组有效率为97.50豫，对照组有效率为82.50豫，两组之间的差异有统计学意义（<0.05）。两组均未发生明显不良反应。结论痰热清联合阿昔洛韦注射液治疗小儿水痘优于单用阿昔洛韦注射液，且安全性高，不良反应少。“,”Objective To observe the clinical effect of Tanreqing injection combined with acyclovir in children with varicella.Methods 80 cases child with varicella were randomly divided into treatment group and control group,each of 40 cases.Treatment group were treated with Tanreqing injection 0.3~0.5ml/kg-1d-1 and Acyclovir 0.01g/kg-1d-1 intravenous drip,one time a day,continous 3~5d;Control group only received acyclovir 0.01g /kg-1d-11intravenous drip,continuous 3~5d.After treatment,compared efficacy of two groups,and observed fever time,rash subsided time and adverse reaction of two groups.Results The total effective rate of treatment group 97.50% was higher than that of control group 82.50%,the difference was statistically significant ( <0.05).The fever time and rash subsided time of treatment group were shorter than those of control group,the difference were statistically significant ( <0.05).NO significant adverse reactions occurred .Conclusion The effect of Tanreqing injection combined with acyclovir in children with varicella is superior to single using acyclovir injection ,and safe,less adverse reaction.